Tocolysis for Women With Early Spontaneous Preterm Labor and Advanced Cervical Dilation

Area of Science:

• Perinatal medicine
• Maternal-fetal medicine
• Neonatology

Background:

• Preterm labor with advanced cervical dilation presents management challenges.
• Tocolytic agents are often used to prolong pregnancy, but their impact on neonatal outcomes in this specific scenario requires clarification.

Purpose of the Study:

• To assess the utilization of tocolytic therapy in women with very preterm labor and advanced cervical dilation (4-8 cm).
• To investigate the association between tocolytic use and perinatal outcomes, including neonatal morbidity.

Main Methods:

• Retrospective cohort study analyzing data from 2000-2011.
• Included women with singleton, non-anomalous fetuses between 23-32 weeks gestation, spontaneous labor, intact membranes, and cervical dilation of 4-8 cm.
• Compared outcomes between women who received tocolytics (magnesium sulfate, indomethacin, nifedipine) and those who did not.

Main Results:

• The majority of women (78.5%) received tocolysis.
• Initial composite severe neonatal morbidity rates were similar between groups (41.6% vs. 43.8%).
• Tocolysis use was associated with a significantly higher likelihood of achieving at least 48 hours of latency (23.6% vs. 7.8%), with similar delivery gestational ages and short-term delivery rates.

Conclusions:

• Tocolytic agents are frequently administered to women with very preterm labor and advanced cervical dilation.
• While tocolysis may extend latency by at least 48 hours, it does not appear to improve initial neonatal morbidity in this population.